The Cancer Research Group at Cell Signaling Technology performs basic research in cancer signal transduction and regularly publishes their findings. The group largely focuses their efforts on non-small cell lung cancer (NSCLC) and was the first to identify novel ALK and ROS1 fusion proteins in NSCLC cell lines and tissue samples. View a full list of publications authored by CST scientists (CST scientists are shown in bold).
